Atra stock forecast.

25 abr 2023 ... Atrás. Cuenta de Cloud Iniciar sesión en ... Proper inventory management involves active monitoring of stocks, the use of technology to forecast ...

Atra stock forecast. Things To Know About Atra stock forecast.

Nov 27, 2023 · Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (2.683 $). Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (3.035 $).AT&T (NYSE:T) pays an annual dividend of $1.11 per share and currently has a dividend yield of 6.81%. T has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for T.ATRA stock had an impressive performance on September 26, 2023, with the potential for significant growth in the coming months. According to CNN Money, seven analysts have provided 12-month price forecasts for Atara Biotherapeutics Inc, with a median target of $20.00.

Jun 30, 2023 · ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock? 12/02/2023. Palantir stock price stood at $20.27. According to the latest long-term forecast, Palantir price will hit $25 by the end of 2023 and then $30 by the middle of 2025. Palantir will rise to $45 within the year of 2026, $55 in 2027, $60 in 2028, $65 in 2029, $70 in 2030, $75 in 2032, $80 in 2033, $85 in 2034 and $90 in 2035.View Atara Biotherapeutics, Inc ATRA investment & stock information. Get the latest Atara Biotherapeutics, Inc ATRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

18 equities research analysts have issued twelve-month price targets for Carnival Co. &'s shares. Their CCL share price targets range from $9.00 to $25.00. On average, they anticipate the company's share price to reach $18.44 in the next year. This suggests a possible upside of 28.0% from the stock's current price.The ARK ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $45.29 and …

Nov 27, 2023 · Price Prediction forecast forAtara Biotherapeutics to November 28, and an in-depth analysis for the week of 26 November to 2 December. Monthly forecasts ATRA for 2023 with target levels, support & resistance insights to make informed investment decisions. ZIM Integrated Shipping Services (NYSE:ZIM) pays an annual dividend of $9.35 per share and currently has a dividend yield of 134.73%. ZIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ZIM.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...15 brokers have issued 1-year price targets for Palantir Technologies' stock. Their PLTR share price targets range from $5.00 to $25.00. On average, they anticipate the company's stock price to reach $13.25 in the next year. This suggests that the stock has a possible downside of 34.6%.

Oct 27, 2023 · Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.

The Trade Desk, Inc. (NASDAQ:TTD) issued its quarterly earnings data on Thursday, November, 9th. The technology company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.05. The technology company had revenue of $493.27 million for the quarter, compared to the consensus estimate of ...

Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ...The percentage change in ATRA’s stock price is not provided. Looking ahead, ATRA’s next reporting date is scheduled for August 9, 2023. Analysts forecast an EPS (earnings per share) of -$0.66 for the current quarter. In the previous year, ATRA reported annual revenue of $63.6 million but incurred a net loss of -$228.3 million.Mar 30, 2023 · Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Dec 3, 2023 · 6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week. Volatility Over Time: ATRA's weekly volatility has increased from 18% to 29% over the past year. Earnings Date. Feb 06, 2024 - Feb 12, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 3.94. Fair Value is the appropriate price for the shares of a company, based ...

Nov 2, 2023 · On November 2, 2023, Atara Biotherapeutics Inc (ATRA) experienced a significant surge in its stock performance following positive price forecasts from analysts. According to data from CNN Money, seven analysts have offered 12-month price forecasts for ATRA, with a median target of $19.00. 12/02/2023. Palantir stock price stood at $20.27. According to the latest long-term forecast, Palantir price will hit $25 by the end of 2023 and then $30 by the middle of 2025. Palantir will rise to $45 within the year of 2026, $55 in 2027, $60 in 2028, $65 in 2029, $70 in 2030, $75 in 2032, $80 in 2033, $85 in 2034 and $90 in 2035.SmartAssetPaid Partner. Find real-time T - AT&T Inc stock quotes, company profile, news and forecasts from CNN Business.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (3.035 $).Atara Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ATRA updated stock price target summary.

Find the latest Workhorse Group Inc. (WKHS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

Nov 27, 2023 · Analyst projections state that ATRA is forecast to be at a low of $0.40 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -4207.69% from its current level, while the stock would need to crash 38.46% from its current level to reach the projected low. Stock Price Forecast. According to 11 stock analysts, the average 12-month stock price forecast for NIO Inc. stock is $12.33, which predicts an increase of 72.45%. The lowest target is $8.00 and the highest is $18. …During the last day, the stock moved $0.0269 between high and low, or 3.59%. For the last week the stock has had daily average volatility of 2.76% . Our recommended stop-loss: $0.740 (-4.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 46 days ago.)What is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 (6.14%) Updated Nov 17, 2023 04:00 PM ET...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Zevra Therapeutics Inc have a median target of 21.00, with a high estimate of 24.00 and a low estimate of 12.00. The ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Nov 24, 2023 · Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions. Find real-time BLRX - BioLine RX Ltd stock quotes, company profile, news and forecasts from CNN Business.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.

We use our expertise to forecast stock prices. [email protected]; Market Opinions. Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice. AIStockFinder will not accept liability for any loss or …

Dec 1, 2023 · Their ATRA share price targets range from $25.00 to $31.00. On average, they expect the company's stock price to reach $28.00 in the next year. This suggests a possible upside of 4,490.2% from the stock's current price. View analysts price targets for ATRA or view top-rated stocks among Wall Street analysts.

Stock Price Forecast. The 26 analysts offering 12-month price forecasts for Medtronic PLC have a median target of 89.50, with a high estimate of 104.00 and a low estimate of 68.00. The median ...Rite Aid Co. (NYSE:RAD) released its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The company earned $6.09 billion during the quarter, compared to analyst estimates of $5.70 billion.Oct 27, 2023 · Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions. The BOIL ETF price gained 0.81% on the last trading day (Thursday, 30th Nov 2023), rising from $36.00 to $36.29. During the last trading day the ETF fluctuated 6.05% from a day low at $35.20 to a day high of $37.33. The price has fallen in 8 of the last 10 days and is down by -29.62% for this period. Volume fell on the last day by -27 …Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Price vs Fair Value. View History. ATRA is trading within a range we consider fairly valued. Price. $0.70. Nov 29, 2023. Fair Value. $1.40. Nov 29, 2023.

Find real-time MO - Altria Group Inc stock quotes, company profile, news and forecasts from CNN Business.Dec 1, 2023 · Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million. Mizuho Securities analyst Salim Syed has maintained their bullish stance on ATRA stock, giving a Buy rating on September 26.. Salim Syed’s rating of Atara Biotherapeutics as a Buy is driven by a ...Instagram:https://instagram. johnson and johnson stock exchange offeris it a good idea to buy landamazon stock price prediction 2023tsly yield The consensus price target of analysts on Wall Street is $10.89, which implies an increase of 97.34% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1.00 and $28.00 respectively. As a result, ATRA is trading at a discount of -9555.17% off the target high and -244.83% off the low.Stock Price Forecast. According to 33 stock analysts, the average 12-month stock price forecast for Apple stock is $197.09, which predicts an increase of 3.05%. The lowest target is $120 and the highest is $240. On average, analysts rate Apple stock as … henry schein sharesmoving stocks from robinhood to etrade The Gevo stock price gained 1.72% on the last trading day (Friday, 24th Nov 2023), rising from $1.16 to $1.18. During the last trading day the stock fluctuated 4.35% from a day low at $1.15 to a day high of $1.20. The price has risen in 7 of the last 10 days and is up by 11.32% over the past 2 weeks. Volume fell on the last day by -2 million ...Stock Price Forecast. According to 38 stock analysts, the average 12-month stock price forecast for Microsoft stock is $392, which predicts an increase of 3.45%. The lowest target is $263 and the highest is $475. On average, analysts rate Microsoft stock as a strong buy. penny stock pre market movers Nov 24, 2023 · THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare Conference 13 analysts have issued 12-month price targets for Delta Air Lines' shares. Their DAL share price targets range from $39.00 to $77.00. On average, they predict the company's stock price to reach $54.40 in the next year. This suggests a possible upside of 43.0% from the stock's current price.